| Literature DB >> 30994980 |
Mónica Romera-Hernández1,2, Laura Mathä2,3, Catherine A Steer2,3, Maryam Ghaedi1,2, Fumio Takei1,2.
Abstract
Innate lymphoid cells (ILCs) are a heterogeneous family of lymphocytes that populate barrier and non-barrier tissues. ILCs regulate immune responses to pathogens and commensals but also sustain metabolic homeostasis, tissue remodeling after injury and establish dialogue with the nervous system. ILCs rapidly become activated in the absence of adaptive antigen receptors by responding to signaling molecules provided by hematopoietic or non-hematopoietic cells. Here we provide protocols designed for processing the lung, liver, small intestine, bone marrow, mediastinal and mesenteric lymph nodes in order to obtain a purified leukocyte fraction of cells, in which ILC2 enrichment is optimized. In addition, we describe in detail the methodologies used to activate ILC2s and the assays necessary for the detection of their effector cytokines. We highlight the differences in ILC2 characterization within distinct tissues that we have recently identified.Entities:
Keywords: group 2 innate lymphoid cells (ILC2s); innate lymphoid cells (ILCs); intranasal infusions; liver; lung; small intestine
Mesh:
Year: 2019 PMID: 30994980 DOI: 10.1002/cpim.73
Source DB: PubMed Journal: Curr Protoc Immunol ISSN: 1934-3671